Skip to content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study

  • Damilya Nugmanova1,
  • Yuriy Feshchenko2,
  • Liudmyla Iashyna2,
  • Olga Gyrina3,
  • Kateryna Malynovska4,
  • Eljan Mammadbayov5,
  • Irada Akhundova5,
  • Nadezhda Nurkina1,
  • Luqman Tariq6,
  • Janina Makarova7, 8Email author and
  • Averyan Vasylyev4
BMC Pulmonary MedicineBMC series – open, inclusive and trusted201818:26

https://doi.org/10.1186/s12890-018-0589-5

Received: 15 October 2017

Accepted: 15 January 2018

Published: 30 January 2018

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
15 Oct 2017 Submitted Original manuscript
6 Nov 2017 Reviewed Reviewer Report - Lori D. Wilson
12 Nov 2017 Reviewed Reviewer Report - Liang Dong
22 Dec 2017 Author responded Author comments - Damilya Nugmanova
Resubmission - Version 2
22 Dec 2017 Submitted Manuscript version 2
12 Jan 2018 Author responded Author comments - Damilya Nugmanova
Resubmission - Version 3
12 Jan 2018 Submitted Manuscript version 3
Publishing
15 Jan 2018 Editorially accepted
30 Jan 2018 Article published 10.1186/s12890-018-0589-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Semey State Medical University, Almaty, Kazakhstan
(2)
National Institute of Phthisiology and Pulmonology F.G. Yanovsky of NAMS, Kiev, Ukraine
(3)
National Medical University n.a. O.O. Bogomoletz, Kiev, Ukraine
(4)
GlaxoSmithKline, Kiev, Ukraine
(5)
Scientific Research Institute of Lung Diseases, Baku, Azerbaijan
(6)
GlaxoSmithKline, Dubai, UAE
(7)
GlaxoSmithKline, Moscow, Russia
(8)
GSK Russia Business Park “Krylatsky Hills”, Moscow, Russia

Advertisement